Dabis F - Search Results

1

Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load.

Bezemer D, de Ronde A, Prins M, Porter K, Gifford R, Pillay D, Masquelier B, Fleury H, Dabis F, Back N, Jurriaans S, van der Hoek L; CASCADE collaboration. Bezemer D, et al. Among authors: dabis f. Antivir Ther. 2006;11(2):173-8. Antivir Ther. 2006. PMID: 16640098

2

Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study.

Toni Td, Masquelier B, Bonard D, Faure M, Huët C, Caumont A, Roques P, Dabis F, Salamon R, Fleury H; Primo-CI/PAC-CI Study Group. Toni Td, et al. Among authors: dabis f. AIDS. 2002 Feb 15;16(3):488-91. doi: 10.1097/00002030-200202150-00024. AIDS. 2002. PMID: 11834964 No abstract available.

3

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernández Aguado I, Pérez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Lee C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, De Angelis D; CASCADE Collaboration. Babiker A, et al. Among authors: dabis f. Int J Epidemiol. 2002 Oct;31(5):951-8. doi: 10.1093/ije/31.5.951. Int J Epidemiol. 2002. PMID: 12435766 Free PMC article.

4

Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study.

Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, Huet C, Chenal H, Rouet F, Dabis F, Lafon ME, Salamon R, Masquelier B, Fleury HJ. Toni TD, et al. Among authors: dabis f. AIDS Res Hum Retroviruses. 2003 Aug;19(8):713-7. doi: 10.1089/088922203322280946. AIDS Res Hum Retroviruses. 2003. PMID: 14506786

5

Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.

Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Neau D, et al. Among authors: dabis f. Clin Infect Dis. 2005 Mar 1;40(5):750-3. doi: 10.1086/427882. Epub 2005 Jan 28. Clin Infect Dis. 2005. PMID: 15714424

6

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group. Thiébaut R, et al. Among authors: dabis f. Antivir Ther. 2005;10(7):811-23. doi: 10.1177/135965350501000706. Antivir Ther. 2005. PMID: 16315369

7

The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.

Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K; CASCADE Virology Collaboration. Pillay D, et al. Among authors: dabis f. AIDS. 2006 Jan 2;20(1):21-8. doi: 10.1097/01.aids.0000196172.35056.b7. AIDS. 2006. PMID: 16327315

8

Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort.

Balestre E, Dupon M, Capdepont S, Thiébaut R, Boucher S, Fleury H, Dabis F, Masquelier B; GECSA. Balestre E, et al. Among authors: dabis f. J Clin Virol. 2006 Jun;36(2):95-9. doi: 10.1016/j.jcv.2006.02.002. Epub 2006 Mar 23. J Clin Virol. 2006. PMID: 16556509

9

Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.

Lazaro E, Coureau G, Guedj J, Blanco P, Pellegrin I, Commenges D, Dabis F, Moreau JF, Pellegrin JL, Thiébaut R; ANRS Co3 Aquitaine Cohort. Lazaro E, et al. Among authors: dabis f. Antivir Ther. 2006;11(3):343-50. Antivir Ther. 2006. PMID: 16759051 Free PMC article.

10

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.

Puoti M, Cozzi-Lepri A, Paraninfo G, Arici C, Moller NF, Lundgren JD, Ledergerber B, Rickenbach M, Suarez-Lozano I, Garrido M, Dabis F, Winnock M, Milazzo L, Gervais A, Raffi F, Gill J, Rockstroh J, Ourishi N, Mussini C, Castagna A, De Luca A, Monforte Ad; HBV-HIV International Intercohort Study Group. Puoti M, et al. Among authors: dabis f. Antivir Ther. 2006;11(5):567-74. doi: 10.1177/135965350601100509. Antivir Ther. 2006. PMID: 16964824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

806 results

Search Page

Filters